Goniotomy in Primary Congenital Glaucoma
Efficacy and Safety of Different Extents of Goniotomy in Primary Congenital Glaucoma
1 other identifier
observational
120
1 country
1
Brief Summary
Brief Summary This is a multicenter cohort study designed to evaluate and compare the efficacy and safety of different surgical extents of goniotomy (GT) - specifically 120°, 240°, and 360° - in the treatment of Primary Congenital Glaucoma (PCG). The study incorporates both retrospective and prospective patient enrollment. PCG is a rare, severe, and blinding childhood eye disease for which surgery, particularly angle surgery, is the primary treatment. Goniotomy, a minimally invasive glaucoma surgery (MIGS), is increasingly used. However, the optimal extent of the angle incision remains uncertain, with limited and conflicting evidence comparing different ranges. The study plans to enroll a total of 120 PCG patients, dividing them into three groups based on the surgical extent received (120°, 240°, or 360°). Patients will be recruited from participating ophthalmic centers across China. The study does not involve interventional assignment; grouping is based on the actual procedure performed as part of standard care. The primary outcome measure is the qualified surgical success rate post-operatively, defined as intraocular pressure (IOP) ≤21 mmHg (with or without medication), without vision-threatening complications or the need for further glaucoma surgery. IOP will be measured by Goldmann or iCare tonometry. Secondary outcomes include various safety indicators such as intraoperative and postoperative complications, the number of intraocular pressure-lowering medications required, visual acuity, and the need for further surgery. The study aims to generate comparative evidence to inform clinical decision-making, potentially contributing to optimized surgical guidelines for PCG treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
April 24, 2026
April 1, 2026
3.1 years
April 12, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Qualified surgery success
The porportion of participants who achieve Intraocular pressure (IOP) ≤ 21 mmHg regardless of topical hypotensive medications, no vision-threatening complications, and no reoperation. The IOP will be measured using Goldmann applanation tonometry or iCare tonometer.
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Complete surgery success
The porportion of participants who achieve Intraocular pressure (IOP) ≤ 21 mmHg without any topical hypotensive medications, no vision-threatening complications, and no reoperation. The IOP will be measured using Goldmann applanation tonometry or iCare tonometer.
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Secondary Outcomes (3)
Topical hypotensive medications
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Surgery complications
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Reoperation
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Other Outcomes (2)
Visual function
Postoperatively Day1, Day 7, Month 1, Month 3, Month 6, Month 9, Month 12, Month 18, Month 24, Month 30, and Month 36.
Economic burden
Postoperatively Month 12, Month 24, and Month 36.
Study Arms (3)
120° goniotomy
By reviewing the surgery record: For 120°GT, in the case of the nasal quadrant, a clear corneal incision, typically 2.2-3.0 mm wide, was made in the temporal quadrant before the injection of ophthalmic viscoelastic devices into the anterior chamber. Subsequently, the patient's head was rotated 35-40 degrees away from the surgeon, and the surgical microscope was tilted 30-40 degrees downward toward the surgeon to enable maximal visualization of the nasal angle. Then, a viscoelastic was applied to the corneal surface, and the surgical goniolens was gently positioned on the cornea and adjusted to observe the nasal angle. A microhook was inserted into the anterior chamber through a corneal incision. The tip of a microhook was then inserted into the Schlemm's canal and moved to incise its inner wall and trabecular meshwork with 120°GT. After aspiration of the ophthalmic viscoelastic devices, the corneal incision was closed.
240-degree goniotomy
By reviewing the surgery record: For 240°GT, two corneal incisions were made, for example, in the superonasal and superotemporal quadrants or in the temporal and superonasal quadrants. Curved hooks, such as TMH, LAN, were specifically used for the incision in the superonasal position.
360-degree goniotomy
By reviewing the surgery record: For 360°GT, a corneal incision was made in temporal quadrant firstly. Viscoelastics were then injected into the anterior chamber to deepen it. A 23-gauge tangential paracentesis was performed in either the superonasal or inferonasal quadrant to allow microcatheter entry. A microcatheter was then inserted into the anterior chamber. Under direct visualization with a surgical goniolens, a 1-2 mm goniotomy was performed at the nasal angle using a microblade. Microsurgical forceps were then used to grasp the microcatheter within the anterior chamber and guide its distal tip into the SC at the goniotomy incision. The microsurgical forceps were used to advance the catheter through the canal circumferentially. Once the distal tip was retrieved after the catheter had passed 360 degrees, it was externalized through the temporal corneal incision. Next, traction was applied to the proximal aspect of the catheter and complete the surgery.
Eligibility Criteria
Participants will be recruited from the outpatient clinics of the glaucoma departments or ophthalmology departments at all participating ophthalmic centers or hospitals. Eligible cases meeting the study criteria will be selected from the medical record systems of these participating centers or hospitals.
You may qualify if:
- Diagnosis of primary congenital glaucoma (PCG).
- Underwent goniotomy (GT) of varying extents and grouped by surgical records (120° or 240°or 360°).
- Either gender; no age limit at surgery.
- Voluntary participation, signed informed consent, and compliance with scheduled follow-up. For legally incompetent patients, participation shall be decided by their guardians, who shall provide written informed consent and agree to follow-up.
- Both eyes are included if data are available for both eyes.
You may not qualify if:
- Concomitant other ocular diseases: including but not limited to diabetic retinopathy, macular degeneration, optic neuropathy, ocular trauma, strabismus, nystagmus, severe dry eye disease, blepharoptosis, or other anterior segment developmental abnormalities.
- The study eye treated with goniotomy (GT) has a history of prior intraocular surgery or ocular trauma.
- Concomitant history of severe systemic diseases: including but not limited to asthma, congenital heart disease, Kawasaki disease, nephropathy, rheumatic and immunologic disorders, digestive system diseases, and malignant neoplasms.
- Women who are pregnant or lactating, or those with an intended pregnancy in the near future.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China
Related Publications (34)
Hu M, Qiao CY, Wang NL. [Research progress in the diagnosis and treatment of childhood glaucoma]. Zhonghua Yan Ke Za Zhi. 2024 May 11;60(5):458-466. doi: 10.3760/cma.j.cn112142-20231202-00266. Chinese.
PMID: 38706086BACKGROUNDMalek I, Sayadi J, Choura R, et al. Outcomes of trabeculotomy for primary congenital glaucoma in a Tunisian population. 2023.
BACKGROUNDAl-Hazmi A, Awad A, Zwaan J, Al-Mesfer SA, Al-Jadaan I, Al-Mohammed A. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005 Apr;89(4):449-53. doi: 10.1136/bjo.2004.047761.
PMID: 15774922BACKGROUNDElhilali HM, El Sayed YM, Elhusseiny AM, Gawdat GI. Kahook Dual Blade Ab-interno Trabeculectomy Compared With Conventional Goniotomy in the Treatment of Primary Congenital Glaucoma: 1-Year Results. J Glaucoma. 2021 Jun 1;30(6):526-531. doi: 10.1097/IJG.0000000000001780.
PMID: 33394855BACKGROUNDMendicino ME, Lynch MG, Drack A, Beck AD, Harbin T, Pollard Z, Vela MA, Lynn MJ. Long-term surgical and visual outcomes in primary congenital glaucoma: 360 degrees trabeculotomy versus goniotomy. J AAPOS. 2000 Aug;4(4):205-10. doi: 10.1067/mpa.2000.106201.
PMID: 10951295BACKGROUNDElwehidy AS, Bayoumi NHL, Abd Elfattah D, Hagras SM. Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe Trabeculotomy in Primary Congenital Glaucoma: A 3-Year Randomized Controlled Study. J Glaucoma. 2022 Jan 1;31(1):48-53. doi: 10.1097/IJG.0000000000001944.
PMID: 34628421BACKGROUNDM Elwan SA, A Abdallah RM, Abdelhalim AS. Microcatheter-assisted circumferential trabeculotomy in primary congenital glaucoma. Saudi J Ophthalmol. 2022 Feb 18;35(2):117-121. doi: 10.4103/1319-4534.337864. eCollection 2021 Apr-Jun.
PMID: 35391820BACKGROUNDNeustein RF, Beck AD. Circumferential Trabeculotomy Versus Conventional Angle Surgery: Comparing Long-term Surgical Success and Clinical Outcomes in Children With Primary Congenital Glaucoma. Am J Ophthalmol. 2017 Nov;183:17-24. doi: 10.1016/j.ajo.2017.08.008. Epub 2017 Aug 30.
PMID: 28860043BACKGROUNDTonset TS, Jakobsen JE, Tveit JH, Jorstad AL, Brevik TB, Sten LB, Drolsum L. Circumferential (360 degrees ) trabeculotomy in primary congenital glaucoma: 19-245 months of follow-up. Acta Ophthalmol. 2021 Dec;99(8):e1449-e1457. doi: 10.1111/aos.14846. Epub 2021 Mar 19.
PMID: 33742566BACKGROUNDWagdy FM. Ab externo 240-degree trabeculotomy versus trabeculotomy-trabeculectomy in primary congenital glaucoma. Int Ophthalmol. 2020 Oct;40(10):2699-2706. doi: 10.1007/s10792-020-01453-x. Epub 2020 Jun 1.
PMID: 32488593BACKGROUNDEl Sayed YM, Gawdat GI. Microcatheter-assisted Trabeculotomy Versus 2-site Trabeculotomy With the Rigid Probe Trabeculotome in Primary Congenital Glaucoma. J Glaucoma. 2018 Apr;27(4):371-376. doi: 10.1097/IJG.0000000000000892.
PMID: 29394197BACKGROUNDElwehidy AS, Hagras SM, Bayoumi N, AbdelGhafar AE, Badawi AE. Five-year results of viscotrabeculotomy versus conventional trabeculotomy in primary congenital glaucoma: A randomized controlled study. Eur J Ophthalmol. 2021 Mar;31(2):786-795. doi: 10.1177/1120672120922453. Epub 2020 May 26.
PMID: 32450720BACKGROUNDKessel L, Pedersen KB, Siersma V, Kappelgaard P, Bach-Holm D. Long-term success after trabeculotomy in primary congenital glaucoma - a study with up to 35 years follow-up. Acta Ophthalmol. 2021 Jun;99(4):362-368. doi: 10.1111/aos.14619. Epub 2020 Sep 10.
PMID: 32914564BACKGROUNDYalvac IS, Satana B, Suveren A, Eksioglu U, Duman S. Success of trabeculotomy in patients with congenital glaucoma operated on within 3 months of birth. Eye (Lond). 2007 Apr;21(4):459-64. doi: 10.1038/sj.eye.6702223. Epub 2006 Jan 6.
PMID: 16397613BACKGROUNDHuang JL, Huang JJ, Zhong YM, Guo XX, Chen XX, Xu XY, Liu X. Surgical Outcomes of Trabeculotomy in Newborns with Primary Congenital Glaucoma. Chin Med J (Engl). 2016 Sep 20;129(18):2178-83. doi: 10.4103/0366-6999.189925.
PMID: 27625089BACKGROUNDEl Hefney EM, Atallah EA, Kishk H, Elwehidy AS, Abd Elfattah D. One-year results of double site versus single site rigid probe viscotrabeculotomy in primary congenital glaucoma. Eur J Ophthalmol. 2025 Jul;35(4):1295-1304. doi: 10.1177/11206721241310269. Epub 2025 Jan 29.
PMID: 39876771BACKGROUNDSong Y, Zhu X, Zhang Y, Shu J, Dang G, Zhou W, Sun L, Li F, Lin F, Zhang Y, Liang X, Wang Z, Zhang Y, Zhang Y, Chen W, Zeng L, Tang L, Xie L, Lam DSC, Wang N, Barton K, Weinreb RN, Zhang X; PVP study group. Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study. J Glaucoma. 2023 Jul 1;32(7):563-568. doi: 10.1097/IJG.0000000000002210. Epub 2023 Mar 30.
PMID: 37054442BACKGROUNDZhang Y, Yu P, Zhang Y, Sugihara K, Zhu X, Zhang Y, Yang X, Li X, Liu Y, Zhang H, Yan X, Zhang H, Lin F, Song Y, Gao X, Yuan H, Tang G, Zhou W, Fan S, Dang G, Tang L, Chen W, Wang N, Park KH, Barton K, Aung T, Lam DSC, Weinreb RN, Xie L, Tanito M, Zeng L, Zhang X; PVP Study Group. Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study. Am J Ophthalmol. 2023 Dec;256:118-125. doi: 10.1016/j.ajo.2023.08.002. Epub 2023 Aug 11.
PMID: 37573988BACKGROUNDPapadopoulos M, Edmunds B, Fenerty C, Khaw PT. Childhood glaucoma surgery in the 21st century. Eye (Lond). 2014 Aug;28(8):931-43. doi: 10.1038/eye.2014.140. Epub 2014 Jun 13.
PMID: 24924446BACKGROUNDShah M, Bouhenni R, Benmerzouga I. Geographical Variability in CYP1B1 Mutations in Primary Congenital Glaucoma. J Clin Med. 2022 Apr 6;11(7):2048. doi: 10.3390/jcm11072048.
PMID: 35407656BACKGROUNDTal-Mushinski E, Imtirat A, Kerman T, Yariv I, Dor O, Amitai N, Saadi R, Elsana B, Tsumi E. Ahmed Glaucoma Valve Implantation Versus Trabeculotomy as Initial Intervention for Primary Congenital Glaucoma-Long-Term Follow-Up. J Glaucoma. 2025 Oct 1;34(10):783-788. doi: 10.1097/IJG.0000000000002580. Epub 2025 Apr 25.
PMID: 40272367BACKGROUNDBayoumi N, Elsayed EN. Secondary intervention after failed initial intervention for primary congenital glaucoma. J Fr Ophtalmol. 2024 Apr;47(4):104077. doi: 10.1016/j.jfo.2024.104077. Epub 2024 Feb 19.
PMID: 38377874BACKGROUNDLai J, Qiao Y, Tan C, Chen J. Outcomes of gonioscopy-assisted transluminal trabeculotomy in primary congenital glaucoma treatment: a retrospective study. BMC Ophthalmol. 2024 Feb 26;24(1):88. doi: 10.1186/s12886-024-03351-7.
PMID: 38408950BACKGROUNDKaushik S, Gupta K, Hunashyal S, Sardana M, Thattaruthody F, Pandav SS. Comparison of Bent Ab-Interno Needle Goniectomy and Goniotomy in Primary Congenital Glaucoma: A Randomized Controlled Trial. Ophthalmol Glaucoma. 2025 Jan-Feb;8(1):46-52. doi: 10.1016/j.ogla.2024.08.003. Epub 2024 Aug 22.
PMID: 39181400BACKGROUNDElwehidy AS, Elhofi AS, Abdelkader AME, GabAllah NM. Two-Year Results of Gonioscopy-Assisted Transluminal Trabeculotomy Versus Ab Externo Visco Circumferential Suture Trabeculotomy in Primary Congenital Glaucoma. J Glaucoma. 2025 Oct 1;34(10):811-818. doi: 10.1097/IJG.0000000000002608. Epub 2025 Jul 10.
PMID: 40637554BACKGROUNDYeung HH, Walton DS. Goniotomy for juvenile open-angle glaucoma. J Glaucoma. 2010 Jan;19(1):1-4. doi: 10.1097/IJG.0b013e3181a2fa31.
PMID: 19373104BACKGROUNDLazcano-Gomez G, Garg SJ, Yeu E, Kahook MY. Interim Analysis of STREAMLINE(R) Surgical System Clinical Outcomes in Eyes with Glaucoma. Clin Ophthalmol. 2022 Apr 27;16:1313-1320. doi: 10.2147/OPTH.S358871. eCollection 2022.
PMID: 35510271BACKGROUNDGupta S, Panigrahi A, R A, Kumar A, Pathak AK, Grover DS, Gupta V. Outcomes of Circumferential Versus Hemi-gonioscopy-Assisted Transluminal Trabeculotomy for Congenital Glaucoma. Am J Ophthalmol. 2025 Mar;271:149-155. doi: 10.1016/j.ajo.2024.10.026. Epub 2024 Nov 7.
PMID: 39515457BACKGROUNDEdo A, Hirooka K, Okumichi H, Yoshinaka A, Kohno S, Kiuchi Y. Surgical outcomes after trabeculotomy for primary congenital glaucoma. Jpn J Ophthalmol. 2025 Jan;69(1):123-130. doi: 10.1007/s10384-024-01152-5. Epub 2025 Jan 24.
PMID: 39853574BACKGROUNDCoviltir V, Marinescu MC, Urse BM, Burcel MG. Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management. Diagnostics (Basel). 2025 Jan 28;15(3):308. doi: 10.3390/diagnostics15030308.
PMID: 39941238BACKGROUNDChang I, Caprioli J, Ou Y. Surgical Management of Pediatric Glaucoma. Dev Ophthalmol. 2017;59:165-178. doi: 10.1159/000458495. Epub 2017 Apr 25.
PMID: 28442696BACKGROUNDGagrani M, Garg I, Ghate D. Surgical interventions for primary congenital glaucoma. Cochrane Database Syst Rev. 2020 Aug 25;8(8):CD008213. doi: 10.1002/14651858.CD008213.pub3.
PMID: 32816311BACKGROUNDEuropean Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021 Jun;105(Suppl 1):1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines.
PMID: 34675001BACKGROUNDLee YJ, Ha A, Kang D, Shim SR, Jeoung JW, Park KH, Kim YK. Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials. Int J Surg. 2023 Apr 1;109(4):953-962. doi: 10.1097/JS9.0000000000000283.
PMID: 36999777BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Attending Physician
Study Record Dates
First Submitted
April 12, 2026
First Posted
April 24, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2029
Last Updated
April 24, 2026
Record last verified: 2026-04